{"disease":{"id":"alkaptonuria","name":"alkaptonuria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00005909","title":"Study of Alkaptonuria","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT04510142","title":"Questionnaire Follow=up Study Sonia 2","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Liverpool University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT04196959","title":"Evaluation of TYR Sphere","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false},{"nct_id":"NCT06298292","title":"Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"metaX Institut fuer Diatetik GmbH","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}